Midazolam attenuates the antinociception induced by D-serine or morphine at the supraspinal level in rats
Midazolam attenuates the antinociception induced by D-serine or morphine at the supraspinal level in rats
复制标题
DOI:
10.1016/j.ejphar.2008.02.068
复制
发表时间:
2008-05-31
影响因子:
5
通讯作者:
Hashimoto, Atsushi
中科院分区:
文献类型:
--
作者:
Ito, Kenji;Yoshikawa, Masanobu;Hashimoto, Atsushi
Our recent study has shown that the intracerebroventricular administration of D-serine, an endogenous and selective agonist for the glycine site of the N-methyl-D-aspartate receptor, alone or in combination with morphine, leads to the potentiation of antinociception on the tail-flick response. Although there is a variety of information concerning the effects of benzodiazepines on opioid-induced antinociception, little is known about the effect of benzodiazepines on the N-methyl-D-aspartate receptor agonist-induced antinociception. To clarify the analgesic interactions among the benzodiazepine/GABA(A), N-methyl-D-aspartate and opioid receptors at the supraspinal level, we investigated the effects of intracerebroventricular administration of midazolam, a benzodiazepine receptor agonist, on the antinociception evoked by the intracerebroventricular application of D-serine or morphine. The intracerebroventricular administration of midazolam alone produced hyperalgesia on the tail-flick response in a benzodiazepine receptor antagonist, flumazenil-reversible manner. The antinociception induced by the intracerebroventricular application of D-serine or morphine was attenuated by the intracerebroventricular administration of miclazolam. In addition, this inhibitory effect of midazolam on the antinociception of D-serine or morphine was antagonized by the intracerebroventricular administration of flumazenil. Together with the facts that D-serine and midazolam act as selective agonists for the glycine site of the N-methyl-D-aspartate receptor and benzodiazepine/GABAA receptor, respectively, these observations suggest a functional interaction between the NMDA and benzodiazepine/GABAA receptors in the regulation of antinociception at the supraspinal level. (C) 2008 Elsevier B.V. All rights reserved.